Cargando…
Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recurrent inflammation that requires lifelong treatments. Probiotic microorganisms appear as an alternative for these patients; however, probiotic characteristics are strain dependent and each probiotic ne...
Autores principales: | de Moreno de LeBlanc, Alejandra, del Carmen, Silvina, Chatel, Jean-Marc, Miyoshi, Anderson, Azevedo, Vasco, Langella, Philippe, Bermúdez-Humarán, Luis G., LeBlanc, Jean Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434185/ https://www.ncbi.nlm.nih.gov/pubmed/26064086 http://dx.doi.org/10.1155/2015/146972 |
Ejemplares similares
-
Correlation between fibronectin binding protein A expression level at the surface of recombinant lactococcus lactis and plasmid transfer in vitro and in vivo
por: Almeida, Juliana F, et al.
Publicado: (2014) -
Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health
por: Levit, Romina, et al.
Publicado: (2022) -
Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis
por: Zurita-Turk, Meritxell, et al.
Publicado: (2014) -
Production of Fibronectin Binding Protein A at the Surface of Lactococcus lactis Increases Plasmid Transfer In Vitro and In Vivo
por: Pontes, Daniela, et al.
Publicado: (2012) -
Importance of IL-10 Modulation by Probiotic Microorganisms in Gastrointestinal Inflammatory Diseases
por: de Moreno de LeBlanc, Alejandra, et al.
Publicado: (2011)